Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Lincoln

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
Neuroscience Letters|August 3, 1999
No pathogenic mutations in the beta-synuclein gene in Parkinson's diseaseS Lincoln, R Crook, M C Chartier-Harlin, et al.
Neurology|August 12, 2004
A limited role for DJ1 in Parkinson disease susceptibilityD M Maraganore, K Wilkes, T G Lesnick, et al.
Neuroscience Letters|February 23, 1999
No pathogenic mutations in the persyn gene in Parkinson's diseaseS Lincoln, K Gwinn-Hardy, J Goudreau, et al.
Nature Medicine|September 30, 1999
Alzheimer disease PS-1 exon 9 deletion definedG Prihar, A Verkkoniem, J Perez-Tur, et al.
Annals of Neurology|September 18, 2001
Lewy bodies and parkinsonism in families with parkin mutationsM Farrer, P Chan, R Chen, et al.
Neurology|February 28, 2002
A multi-incident, Old-Order Amish family with PDB A Racette, M Rundle, J C Wang, et al.
European Journal of Human Genetics : EJHG|September 26, 2001
Refinement of the PARK3 locus on chromosome 2p13 and the analysis of 14 candidate genesA B West, A Zimprich, P J Lockhart, et al.
Human Molecular Genetics|January 15, 1999
A chromosome 4p haplotype segregating with Parkinson's disease and postural tremorM Farrer, K Gwinn-Hardy, M Muenter, et al.
Neurobiology of Disease|July 10, 2001
Lack of nigral pathology in transgenic mice expressing human alpha-synuclein driven by the tyrosine hydroxylase promoterY Matsuoka, M Vila, S Lincoln, et al.
Human Molecular Genetics|May 16, 1998
Sequencing of the alpha-synuclein gene in a large series of cases of familial Parkinson's disease fails to reveal any further mutations. The European Consortium on Genetic Susceptibility in Parkinson's Disease (GSPD)J R Vaughan, M J Farrer, Z K Wszolek, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
Neuroscience Letters|August 3, 1999
No pathogenic mutations in the beta-synuclein gene in Parkinson's diseaseS Lincoln, R Crook, M C Chartier-Harlin, et al.
Neurology|August 12, 2004
A limited role for DJ1 in Parkinson disease susceptibilityD M Maraganore, K Wilkes, T G Lesnick, et al.
Neuroscience Letters|February 23, 1999
No pathogenic mutations in the persyn gene in Parkinson's diseaseS Lincoln, K Gwinn-Hardy, J Goudreau, et al.
Nature Medicine|September 30, 1999
Alzheimer disease PS-1 exon 9 deletion definedG Prihar, A Verkkoniem, J Perez-Tur, et al.
Annals of Neurology|September 18, 2001
Lewy bodies and parkinsonism in families with parkin mutationsM Farrer, P Chan, R Chen, et al.
Neurology|February 28, 2002
A multi-incident, Old-Order Amish family with PDB A Racette, M Rundle, J C Wang, et al.
European Journal of Human Genetics : EJHG|September 26, 2001
Refinement of the PARK3 locus on chromosome 2p13 and the analysis of 14 candidate genesA B West, A Zimprich, P J Lockhart, et al.
Human Molecular Genetics|January 15, 1999
A chromosome 4p haplotype segregating with Parkinson's disease and postural tremorM Farrer, K Gwinn-Hardy, M Muenter, et al.
Neurobiology of Disease|July 10, 2001
Lack of nigral pathology in transgenic mice expressing human alpha-synuclein driven by the tyrosine hydroxylase promoterY Matsuoka, M Vila, S Lincoln, et al.
Human Molecular Genetics|May 16, 1998
Sequencing of the alpha-synuclein gene in a large series of cases of familial Parkinson's disease fails to reveal any further mutations. The European Consortium on Genetic Susceptibility in Parkinson's Disease (GSPD)J R Vaughan, M J Farrer, Z K Wszolek, et al.
Pageof 6